Fibrobesity – Preventing Fibrosis Related to Obesity

Fibrobesity – Preventing Fibrosis Related to Obesity - is one of the three multidisciplinary research programmes supported by the Academy of Finland PROFI6 funding during 2021-2026. Fibrobesity links strongly with the strategy of the University of Oulu under a wider umbrella of FibroHealth – Combatting Fibrosis in Chronic Diseases. While FibroHealth at large addresses fibrosis, which is a risk factor in the etiology of complex chronic diseases and unhealthy aging, Fibrobesity focuses on medical and societal challenges of obesity-related fibrotic pathologies. The research community extends to several faculties and research areas from medicine, biochemistry, and molecular medicine to human, education, and ICT sciences.

Fibrobesity Research in a Nutshell

The world-class research at the University of Oulu on hypoxia and extracellular matrix (ECM) together with cutting-edge research on obesity, cardiovascular risk factors, metabolic syndrome, polycystic ovary syndrome, and other fibrosis-related diseases, combined with our unique population and patient cohort studies and state-of-the-art research infrastructure, form the basis of Fibrobesity.

Research Themes

Contact Us

Fibrobesity Newsletter

The Fibrobesity Research Programme publishes a regular newsletter every two months. We have put together an archive of our old newsletters here. The latest newsletters will also be added to the archive shortly after publication. We warmly welcome you to get to know our community!

The newsletter publication dates for 2024 are:

  • 14 February,
  • 10 April,
  • 12 June,
  • 21 August,
  • 9 October and
  • 11 December.